CompletedNot Applicable

Intraoperative Biodegradable Stent Placement to Reduce Complications After Pancreatoduodenectomy

Denmark50 participantsStarted 2023-10-01

Plain-language summary

The aim of this prospective, randomized, blinded clinical superiority trial is to establish intraoperative placement of biodegradable stents in the pancreatojejunostomy as a safe, effective, and feasible preventive measure against pancreatic fistula following pancreatoduodenectomy. The investigators hypothesize that intraoperative placement of biodegradable stents in the pancreatojejunostomy is safe and can reduce the risk of pancreatic leakage following pancreatoduodenectomy in patients who have not undergone PBD.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients undergoing a pancreatoduodenectomy
✓. Patients aged 18 or above
✓. Patients who have given an informed consent

Exclusion criteria

✕. Patients who do not or cannot give an informed consent.
✕. Patients with at a high risk or with previous history of multiple thrombo-embolic diseases or bleeding disorders.
✕. Patients undergoing active immunosuppressive therapy.

What they're measuring

POPF

Timeframe: 30 days

Number of participants with a Biliary fistula

Timeframe: 30 days

Trial details

NCT IDNCT06205693

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-01

View on ClinicalTrials.gov More Fistula Pancreatic trials